Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 43 filers reported holding Y-MABS THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $4,329,000 | +61.6% | 138,514 | +34.7% | 0.02% | +27.8% |
| Q3 2019 | $2,679,000 | +14.0% | 102,800 | 0.0% | 0.02% | +12.5% |
| Q2 2019 | $2,351,000 | -12.7% | 102,800 | 0.0% | 0.02% | -5.9% |
| Q1 2019 | $2,694,000 | +28.8% | 102,800 | 0.0% | 0.02% | 0.0% |
| Q4 2018 | $2,091,000 | -47.5% | 102,800 | -31.5% | 0.02% | -34.6% |
| Q3 2018 | $3,984,000 | – | 150,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 216,916 | $6,191,000 | 3.86% |
| Sofinnova Investments, Inc. | 2,194,278 | $62,625,000 | 3.71% |
| MPM BioImpact LLC | 452,970 | $12,928,000 | 2.00% |
| Soleus Capital Management, L.P. | 265,700 | $7,583,000 | 1.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 452,110 | $12,903,000 | 1.17% |
| ORACLE INVESTMENT MANAGEMENT INC | 315,642 | $9,008,000 | 1.12% |
| First Light Asset Management, LLC | 577,663 | $16,487,000 | 1.09% |
| Lombard Odier Asset Management (Switzerland) SA | 352,839 | $10,070,000 | 0.62% |
| Cormorant Asset Management, LP | 500,000 | $14,270,000 | 0.58% |
| Artal Group S.A. | 400,000 | $11,416,000 | 0.26% |